IRVINE, Calif. , Feb. 14, 2023 /PRNewswire/ -- Chargel, a one-of-a-kind athletic gel drink designed to meet the unique energy needs of athletes with unexpected, immediate pre-workout energy today announced it is a proud sponsor of UCLA Athletics. This sponsorship will help keep athletes and fans alike fueled with the brand's caffeine-free, on-the-go, instant energy gel drinks.
The sponsorship for the 2023 includes several activations at the Men's Basketball games. Prior to select games, students will be able to sample Chargel as they wait in line outside of Pauley Pavilion located at 301 Westwood Plaza, Los Angeles, CA 90095. Additionally, Chargel will sponsor "The Dirt," UCLA's pre-game one sheeter that spills the tea, so-to-speak, on the opposing team. During games, fans traditionally rip up the paper into small pieces to be thrown after UCLA scores their first basket. As the First Basket Confetti is hurled, a graphic will run stating, the first basket is sponsored by Chargel.
"As a brand based in Southern California , we're very excited to support the UCLA Bruins and their fans in their quests for victory," said Teruhiro Kawabe , Chief Representative for the USA and President/CEO of Morinaga America, Inc., the U.S. sales company of Chargel. "These student athletes give their all each and every game, and we're extremely proud to help give them a boost of energy without the jitters."
Available in three easy to consume and delicious flavors, including White Grape, Green Apple, and Strawberry, Chargel's immediate energy comes from an exclusive blend of carbohydrates, fruit juice, and five essential B vitamins. Each serving of Chargel packs 20% of the daily value of niacin, thiamin, riboflavin, B12 and B6, without any caffeine, artificial sweeteners, or high fructose corn syrup.
All Chargel gel drinks are plant-based, gluten-free, and free of the nine major allergens. They can be purchased online at Amazon.com and www.chargel.com in packs of six pouches, with an SRP of $20.94 or individually for $3.49 per pouch. To learn more about partnering with Chargel, email infochargel@morinaga-america.com.
Launched in 2022, Chargel is a first-of-its-kind, delicious athletic Gel Drink that delivers convenient, and delightfully unexpected instant energy before any workout with zero caffeine. Half snack and half beverage, Chargel Gel Drinks offer the satisfaction of a snack and refreshment of a drink, in one unique pocket-sized, on-the-go pouch. Available in three great-tasting crushable flavors, White Grape, Green Apple and Strawberry, Chargel Gel Drinks feature an exclusive blend of carbohydrates, fruit juice, and five essential B vitamins – including 20% daily value niacin, thiamin, riboflavin, B12 and B6 – without any artificial sweeteners or high fructose corn syrup. The Gel Drinks were thoughtfully developed for convenience and fast intake before activity and feature a built-in spout for quick delivery. For more information, please visit www.chargel.com.
Established in 2008, Morinaga America, Inc. has achieved tremendous growth as the official distributor of HI-CHEW and Chargel™. In 2022, Morinaga America's sales marked around 500% growth since 2015, and now rank in 10th position in the non-chocolate category per IRI Data. The company has developed a plethora of unique products in Japan and Hi-Chew's significant success story helped pave the way to Morinaga's entrance into the U.S. market with the launch of Chargel™ introducing gel drinks to U.S. consumers, a category it has pioneered in Japan . Morinaga's next mission is to introduce another distinctive product in the US market, aiming for another big success.
Media Contact Melissa Kanter Rachel Kay Public Relations, A FINN Partners Company 201-213-3239 melissa.kanter@finnpartners.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/chargel-becomes-proud-sponsor-of-ucla-athletics-301745611.html
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
MARKET PULSE Gilead Sciences Inc. (GILD) said Tuesday that its COVID-19 drug can help reduce deaths and readmission rates among patients hospitalized with COVID-19 and who received the drug, remdesivir, shortly after their hospital admission.
Merck & Co Inc (NYSE: MRK) Lagevrio (molnupiravir) did not demonstrate a statistically significant reduction in the risk of COVID-19 following household exposure to another individual with COVID-19. The Phase 3 MOVe-AHEAD trial evaluated people who did not have COVID-19 at baseline (confirmed by a negative baseline SARS-CoV-2 test and no signs and symptoms) but lived with someone who was recently diagnosed with COVID-19. Related: Merck's Oral COVID-19 Treatment Might Be Linked To Spreading Mutat
WASHINGTON— Amazon.com will be able to close its purchase of 1Life Healthcare the operator of the One Medical line of primary-care clinics, without a legal challenge by antitrust enforcers. The Federal Trade Commission won’t sue in time to block the $3.9 billion deal, including debt, but will continue its investigation of the merger, an agency spokesman said. The decision clears a path for Amazon to substantially expand its healthcare offerings and operate physical medical clinics.
Regeneron's (REGN) application seeking approval of pozelimab for the ultra-rare hereditary immune disease CHAPLE gets Priority Review by the FDA.
“This cuts the virus off at its knees," said the co-author of a presentation at the CROI meeting this week.
Gilead's (GILD) new and updated positive results from a phase II study show Trodelvy's rapid and durable responses for patients across a range of hard-to-treat types of mUC.
Big Tech and others defending Instagram and its ilk don't address a youth mental health crisis in their filings with the Supreme Court in a Section 230 case.
The Oracle of Omaha knows how to beat inflation. So ride his coattails.
Michael Burry’s fame spread far and wide after his exploits were documented in the Big Short – the book - and later the movie - that told the story of Burry’s success in betting against the housing market during the financial crisis of 2008. That was a move that turned out to be a hugely profitable one. Burry went short then and hasn’t been shy in issuing repeated warnings on the current state of the market, either. In addition to some recent enigmatic tweets that hint at looming disaster, Burry
The chairman of the Board of Directors of the second largest Swiss bank is under investigation by the Swiss authorities.
Inflation, interest rates, and recession – these are the bogeymen of investing, and they’ve been watching over our shoulders for the past year. We all know the story by now, the rate of inflation, at 6.4%, is still high, the Federal Reserve is hiking rates in an attempt to push back against high prices, and that could tip the economy into recession. At a time like this, investors are showing a growing interest in finding strong defensive portfolio moves. It’s a mindset that naturally turns us to
Super rich people may avoid paying more than $160 billion in taxes every year, the Treasury says. Here are some strategies they use to do that.
We are entering into what could be a prolonged battle over the future of Social Security and Medicare.
Transocean (RIG) delivered earnings and revenue surprises of -157.89% and 0.56%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
The largest electric-vehicle battery maker in the world, CATL, will offer a unique pricing structure for its product. The deal spooked lithium investors.
Once you have $1 million in assets, you can look seriously at living entirely off the returns of a portfolio. After all, the S&P 500 alone averages 10% returns per year. Setting aside taxes and down-year investment portfolio management, a … Continue reading → The post How Much Interest Can You Earn on $1 million? appeared first on SmartAsset Blog.
It's a tech-astrophe out there. But you have options.
(Bloomberg) -- Shares of Domino’s Pizza Enterprises Ltd. plummeted the most on record in Sydney after the pizza chain operator said its first-half earnings fell as customers spurned price increases meant to offset inflationary pressures.Most Read from BloombergHow Much Do Investors Say They Need to Retire? At Least $3 MillionMcKinsey Plans to Eliminate About 2,000 Jobs in One of Its Biggest Rounds of CutsRussia’s War on Ukraine, China’s Rise Expose US Military FailingsWorld’s Largest Four-Day Wo
“With consumption and inflation reheating, risks of a hard landing resembling a boom/bust are growing,” Lisa Shalett, Morgan Stanley Wealth Management’s CIO, warns.